Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Articaine Hydrochloride for Dental Local Anesthesia
jRCT1051250186Not yet recruiting
- Sponsor
- GC Showa Yakuhin
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of articaine and lidocaine in impacted third molar (I3M) and carious lesion (2 arms), sponsored by GC Showa Yakuhin. Primary endpoint: Patient pain assessment. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
articainelidocaine
03
Conditions
impacted third molar (I3M)carious lesion
Beyond the preview
Go deeper on jRCT1051250186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051250186.